[1]
|
Dalmau, J. and Graus, F. (2018) Antibody-Mediated Encephalitis. The New England Journal of Medicine, 378, 840-851. https://doi.org/10.1056/NEJMra1708712
|
[2]
|
Hiesgen, J. and Schutte, C. (2023) Autoimmune Encephalitis: Part 1 (Epidemiology, Pathophysiology and Clinical Spectrum). South African Medical Journal, 113, 116-121. https://doi.org/10.7196/SAMJ.2023.v113i3.780
|
[3]
|
Orozco, E., Valencia-Sanchez, C., Britton, J., et al. (2023) Autoimmune Encephalitis Criteria in Clinical Practice. Neurology. Clinical Practice, 13, e200151. https://doi.org/10.1212/CPJ.0000000000200151
|
[4]
|
Blattner, M.S., de Bruin, G.S., Bucelli, R.C. and Day, G.S. (2019) Sleep Disturbances Are Common in Patients with Autoimmune Encephalitis. Journal of Neurology, 266, 1007-1015. https://doi.org/10.1007/s00415-019-09230-2
|
[5]
|
Iranzo, A. (2020) Sleep and Neurological Autoim-mune Diseases. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 45, 129-140. https://doi.org/10.1038/s41386-019-0463-z
|
[6]
|
Cornelius, J.R., Pittock, S.J., McKeon, A., et al. (2011) Sleep Manifestations of Voltage-Gated Potassium Channel Complex Autoimmunity. Archives of Neurology, 68, 733-738. https://doi.org/10.1001/archneurol.2011.106
|
[7]
|
Heine, J., Duchow, A., Rust, R., Paul, F., Prüß, H. and Finke, C. (2023) Autoimmune Encephalitis—An Update. Der Nervenarzt, 94, 525-537. https://doi.org/10.1007/s00115-022-01411-1
|
[8]
|
Braczkowski, M., Soszyński, D., Sierakowska, A., Braczkowski, R., Kufel, K. and Łabuz-Roszak, B. (2023) Autoimmune Encephalitis with Antibodies: Anti-NMDAR, Anti-AMPAR, Anti-GQ1b, Anti-DPPX, Anti-CASPR2, Anti-LGI1, Anti-RI, Anti-Yo, Anti-Hu, Anti-CV2 and Anti-GABAAR, in the Course of Psychoses, Neoplastic Diseases, and Paraneoplastic Syndromes. Diagnostics (Basel, Switzerland), 13, Article No. 2589.
https://doi.org/10.3390/diagnostics13152589
|
[9]
|
Pérez-Carbonell, L. and Iranzo, A. (2023) Sleep Disturbances in Autoimmune Neurological Diseases. Current Neurology and Neuroscience Reports, 23, 617-625. https://doi.org/10.1007/s11910-023-01294-y
|
[10]
|
Titulaer, M.J., McCracken, L., Gabilondo, I., et al. (2013) Treatment and Prognostic Factors for Long-Term Outcome in Patients with Anti-NMDA Receptor Encephalitis: An Ob-servational Cohort Study. The Lancet Neurology, 12, 157-165. https://doi.org/10.1016/S1474-4422(12)70310-1
|
[11]
|
Samanta, D. and Lui, F. (2023) Anti-NMDAR Encephalitis. StatPearls Publishing, Treasure Island.
|
[12]
|
Hacohen, Y., Deiva, K., Pettingill, P., et al. (2014) N-methyl-D-aspartate Receptor Antibodies in Post-Herpes Simplex Virus Encephalitis Neurological Relapse. Movement Disorders: Official Journal of the Movement Disorder Society, 29, 90-96. https://doi.org/10.1002/mds.25626
|
[13]
|
Ariño, H., Muñoz-Lopetegi, A., Martinez-Hernandez, E., et al. (2020) Sleep Disorders in Anti-NMDAR Encephalitis. Neurology, 95, e671-e684. https://doi.org/10.1212/WNL.0000000000009987
|
[14]
|
Marques, I.B., Teotónio, R., Cunha, C., Bento, C. and Sales, F. (2014) Anti-NMDA Receptor Encephalitis Presenting with Total Insomnia—A Case Report. Journal of the Neurological Sciences, 336, 276-280.
https://doi.org/10.1016/j.jns.2013.10.034
|
[15]
|
Afolabi-Brown, O. and Mason, T.B.A. (2018) Kleine-Levin Syn-drome. Paediatric Respiratory Reviews, 25, 9-13.
https://doi.org/10.1016/j.prrv.2016.12.004
|
[16]
|
van Sonderen, A., Petit-Pedrol, M., Dalmau, J. and Titulaer, M.J. (2017) The Value of LGI1, Caspr2 and Voltage-Gated Potassium Channel Antibodies in Encephalitis. Nature Reviews Neurology, 13, 290-301.
https://doi.org/10.1038/nrneurol.2017.43
|
[17]
|
Gadoth, A., Pittock, S.J., Dubey, D., et al. (2017) Expanded Pheno-types and Outcomes among 256 LGI1/CASPR2- IgG-Positive Patients. Annals of Neurology, 82, 79-92. https://doi.org/10.1002/ana.24979
|
[18]
|
Gadoth, A., Nisnboym, M., Alcalay, Y., et al. (2023) Electrolyte Imbalance in Anti-LGI1 Encephalitis: It Is Not All in Your Head. Neurology Neuroimmunology & Neuroinflammation, 10, e200155.
https://doi.org/10.1212/NXI.0000000000200155
|
[19]
|
Kong, D.-L. (2023) Anti-Leucine-Rich Glioma Inactivated Protein 1 Encephalitis with Sleep Disturbance as the First Symptom: A Case Report and Review of Literature. World Journal of Clinical Cases, 11, 408-416.
https://doi.org/10.12998/wjcc.v11.i2.408
|
[20]
|
Lin, N., Hao, H., Guan, H., et al. (2020) Sleep Disorders in Leu-cine-Rich Glioma-Inactivated Protein 1 and Contactin Protein-Like 2 Antibody-Associated Diseases. Frontiers in Neu-rology, 11, Article No. 696.
https://doi.org/10.3389/fneur.2020.00696
|
[21]
|
Liu, X., Yang, L., Han, Y., et al. (2021) Electrophysiological Evalu-ation in Identifying Unique Sleep Features among Anti-LGI1 Encephalitis Patients during Active and Recovery Phase. Nature and Science of Sleep, 13, 527-536.
https://doi.org/10.2147/NSS.S299467
|
[22]
|
Uchida, S., Soya, S., Saito, Y.C., et al. (2021) A Discrete Glycinergic Neuronal Population in the Ventromedial Medulla That Induces Muscle Atonia during REM Sleep and Cataplexy in Mice. The Journal of Neuroscience: The Official Journal of the Society For Neuroscience, 41, 1582-1596. https://doi.org/10.1523/JNEUROSCI.0688-20.2020
|
[23]
|
van Sonderen, A., Ariño, H., Petit-Pedrol, M., et al. (2016) The Clinical Spectrum of Caspr2 Antibody-Associated Disease. Neurology, 87, 521-528. https://doi.org/10.1212/WNL.0000000000002917
|
[24]
|
Masood, W. and Sitammagari, K.K. (2023) Morvan Syn-drome. StatPearls Publishing, Treasure Island.
|
[25]
|
Irani, S.R., Pettingill, P., Kleopa, K.A., et al. (2012) Morvan Syn-drome: Clinical and Serological Observations in 29 Cases. Annals of Neurology, 72, 241-255. https://doi.org/10.1002/ana.23577
|
[26]
|
Gauld, C., Lopez, R., Geoffroy, P.A., et al. (2021) A Systematic Analysis of ICSD-3 Diagnostic Criteria and Proposal for Further Structured Iteration. Sleep Medicine Reviews, 58, Article ID: 101439.
https://doi.org/10.1016/j.smrv.2021.101439
|
[27]
|
Abgrall, G., Demeret, S., Rohaut, B., Leu-Semenescu, S. and Arnulf, I. (2015) Status Dissociatus and Disturbed Dreaming in a Patient with Morvan Syndrome plus Myasthenia Gravis. Sleep Medicine, 16, 894-896.
https://doi.org/10.1016/j.sleep.2015.03.017
|
[28]
|
Grüter, T., Möllers, F.E., Tietz, A., et al. (2023) Clinical, Serolog-ical and Genetic Predictors of Response to Immunotherapy in Anti-IgLON5 Disease. Brain, 146, 600-611. https://doi.org/10.1093/brain/awac090
|
[29]
|
Theis, H., Bischof, G.N., Brüggemann, N., et al. (2023) In Vivo Meas-urement of Tau Depositions in Anti-IgLON5 Disease Using (18)F-PI-2620 PET. Neurology. https://doi.org/10.1212/WNL.0000000000207870
|
[30]
|
Gaig, C., Graus, F., Compta, Y., et al. (2017) Clinical Manifestations of the Anti-IgLON5 Disease. Neurology, 88, 1736-1743. https://doi.org/10.1212/WNL.0000000000003887
|
[31]
|
Grossauer, A., Hussl, A., Mahlknecht, P., et al. (2023) An-ti-IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature. Movement Disorders Clinical Practice, 10, 115-119. https://doi.org/10.1002/mdc3.13614
|
[32]
|
Sabater, L., Gaig, C., Gelpi, E., et al. (2014) A Novel Non-Rapid-Eye Movement and Rapid-Eye-Movement Parasomnia with Sleep Breathing Disorder Associated with Antibodies to IgLON5: A Case Series, Characterisation of the Antigen, and Post-Mortem Study. The Lancet Neurology, 13, 575-586. https://doi.org/10.1016/S1474-4422(14)70051-1
|
[33]
|
Gaig, C., Iranzo, A., Santamaria, J. and Graus, F. (2018) The Sleep Disorder in Anti-lgLON5 Disease. Current Neurology and Neuroscience Reports, 18, Article No. 41. https://doi.org/10.1007/s11910-018-0848-0
|
[34]
|
Gaig, C., Compta, Y., Heidbreder, A., et al. (2021) Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. Neurology, 97, e1367-e1381.
|
[35]
|
Gelpi, E., Höftberger, R., Graus, F., et al. (2016) Neuropathological Criteria of Anti-IgLON5-Related Tauopathy. Acta Neuropa-thologica, 132, 531-543. https://doi.org/10.1007/s00401-016-1591-8
|
[36]
|
Gaig, C., Iranzo, A., Cajochen, C., et al. (2019) Characterization of the Sleep Disorder of Anti-IgLON5 Disease. Sleep, 42, zsz133. https://doi.org/10.1093/sleep/zsz133
|
[37]
|
Akset, M., Poppe, K.G., Kleynen, P., Bold, I. and Bruyneel, M. (2023) Endocrine Disorders in Obstructive Sleep Apnoea Syndrome: A Bidirectional Relationship. Clinical Endocrinology (Ox-ford), 98, 3-13.
https://doi.org/10.1111/cen.14685
|
[38]
|
Tondo, P., Fanfulla, F., Sabato, R., Scioscia, G., Foschino Barbaro, M.P. and Lacedonia, D. (2023) Obstructive Sleep Apnoea-Hypopnoea Syndrome: State of the Art. Minerva Medica, 114, 74-89.
https://doi.org/10.23736/S0026-4806.22.08190-3
|
[39]
|
Tankéré, P., Le Cam, P., Folliet, L., et al. (2023) Unveiled Central Hypoventilation after Tracheotomy in Anti-IgLON5 Disease: A Case Report. Journal of Clinical Sleep Medicine, 19, 1701-1704. https://doi.org/10.5664/jcsm.10658
|
[40]
|
Joubert, B., Kerschen, P., Zekeridou, A., et al. (2015) Clinical Spectrum of Encephalitis Associated with Antibodies against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor: Case Series and Review of the Literature. JAMA Neurology, 72, 1163-1169. https://doi.org/10.1001/jamaneurol.2015.1715
|
[41]
|
Schäfer, J., Christensen, P.B. and Jensen, K. (2023) AMPA and NMDA Receptor Antibody Autoimmune Encephalitis Preceded by Ocular Myasthenia Gravis: A Case Report. BMC Neurology, 23, Article No. 102.
https://doi.org/10.1186/s12883-023-03129-2
|
[42]
|
Lai, M., Hughes, E.G., Peng, X., et al. (2009) AMPA Receptor Antibodies in Limbic Encephalitis Alter Synaptic Receptor Location. Annals of Neurology, 65, 424-434. https://doi.org/10.1002/ana.21589
|
[43]
|
Hara, M., Ariño, H., Petit-Pedrol, M., et al. (2017) DPPX Anti-body-Associated Encephalitis: Main Syndrome and Antibody Effects. Neurology, 88, 1340-1348. https://doi.org/10.1212/WNL.0000000000003796
|
[44]
|
Bjerknes, T.L., Steihaug, O.M., Haugen, M., Hjelland, I.E. and Vedeler, C.A. (2022) Case Report: Pain in Anti-DPPX Encephalitis. Frontiers in Neurology, 13, Article ID: 1091688. https://doi.org/10.3389/fneur.2022.1091688
|
[45]
|
Gadoth, A., Devine, M.F., Pittock, S.J., et al. (2023) Sleep Disturbances Associated with DPPX Autoantibodies: A Case Series. Journal of Neurology, 270, 3543-3552. https://doi.org/10.1007/s00415-023-11698-y
|
[46]
|
Sateia, M.J. (2014) International Classification of Sleep Disor-ders-Third Edition: Highlights and Modifications. Chest, 146, 1387-1394. https://doi.org/10.1378/chest.14-0970
|
[47]
|
Williams, C.M., Allison, D.B., Coleman, A.B., Bardhan, R., Miller, J.D. and Myint, Z.W. (2023) Primary Mediastinal Seminoma Presenting with Paraneoplastic Anti-Hu Encephalitis: A Case Report and Literature Review. Frontiers in Oncology, 13, Article ID: 1156566. https://doi.org/10.3389/fonc.2023.1156566
|
[48]
|
Budhram, A., Sharma, M. and Young, G.B. (2022) Seizures in Anti-Hu-Associated Extra-Limbic Encephalitis: Characterization of a Unique Disease Manifestation. Epilepsia, 63, e172-e177. https://doi.org/10.1111/epi.17437
|
[49]
|
Saiz, A., Bruna, J., Stourac, P., et al. (2009) An-ti-Hu-Associated Brainstem Encephalitis. Journal of Neurology, Neurosurgery and Psychiatry, 80, 404-407. https://doi.org/10.1136/jnnp.2008.158246
|
[50]
|
Graus, F., Saiz, A. and Dalmau, J. (2010) Antibodies and Neuronal Autoimmune Disorders of the CNS. Journal of Neurology, 257, 509-517. https://doi.org/10.1007/s00415-009-5431-9
|
[51]
|
Lamby, N., Leypoldt, F., Schulz, J.B. and Tauber, S.C. (2019) Atypical Presentation of Anti-Ma2-Associated Encephalitis with Choreiform Movement. Neurology(R) Neuroimmunol-ogy & Neuroinflammation, 6, e557.
https://doi.org/10.1212/NXI.0000000000000557
|
[52]
|
Pilli, D., Zou, A., Tea, F., Dale, R.C. and Brilot, F. (2017) Expanding Role of T Cells in Human Autoimmune Diseases of the Central Nervous System. Frontiers in Immunology, 8, Article No. 652.
https://doi.org/10.3389/fimmu.2017.00652
|
[53]
|
Wernz, C., Pupa, L., Ossimetha, A., Ansari, S. and Moron, F. (2023) Anti-Ma2 Encephalitis: An Atypical Case Associated with Klüver-Bucy Syndrome and Hypothalamic Dysfunc-tion. Cureus, 15, e40816.
https://doi.org/10.7759/cureus.40816
|
[54]
|
Dalmau, J., Graus, F., Villarejo, A., et al. (2004) Clinical Analysis of Anti-Ma2-Associated Encephalitis. Brain, 127, 1831-1844. https://doi.org/10.1093/brain/awh203
|
[55]
|
Brunet de Courssou, J.B., Testard, P., Sallansonnet-Froment, M., et al. (2023) Narcolepsy Secondary to Anti-Ma2 Encephalitis: Two Case Reports. Journal of Clinical Sleep Medicine, 19, 837-841. https://doi.org/10.5664/jcsm.10448
|
[56]
|
Dauvilliers, Y., Bauer, J., Rigau, V., et al. (2013) Hypothalamic Immuno-pathology in Anti-Ma-Associated Diencephalitis with Narcolepsy-Cataplexy. JAMA Neurology, 70, 1305-1310. https://doi.org/10.1001/jamaneurol.2013.2831
|
[57]
|
Anderson, K.N., Kelly, T.P. and Griffiths, T.D. (2013) Primary Sleep Disorders Can Cause Long-Term Sleep Disturbance in Patients with Autoimmune Mediated Limbic Encephalitis. Clinical Neurology and Neurosurgery, 115, 1079-1082.
https://doi.org/10.1016/j.clineuro.2012.10.031
|
[58]
|
Rundo, J.V. and Downey III, R. (2019) Polysomnography. Handbook of Clinical Neurology, 160, 381-392.
https://doi.org/10.1016/B978-0-444-64032-1.00025-4
|
[59]
|
Koo, D.L. (2023) Sleep Disturbances in Autoim-mune Encephalitis. Encephalitis, 3, 1-6.
https://doi.org/10.47936/encephalitis.2022.00073
|
[60]
|
Ørskov, P.T. and Norup, A. (2023) Validity and Reliability of the Danish Version of the Pittsburgh Sleep Quality Index. Scandinavian Journal of Public Health, 51, 1182-1188. https://doi.org/10.1177/14034948221100099
|
[61]
|
Gonçalves, M.T., Malafaia, S., Moutinho Dos Santos, J., Roth, T. and Marques, D.R. (2023) Epworth Sleepiness Scale: A Meta-Analytic Study on the Internal Consistency. Sleep Med-icine, 109, 261-269.
https://doi.org/10.1016/j.sleep.2023.07.008
|
[62]
|
Navarrete-Martínez, E., Muñoz-Gómez, R., Serrano-Merino, J., et al. (2023) Validity and Reliability of the Berlin Questionnaire for the Detection of Moderate or Severe Obstructive Sleep Apnea in Patients Aged 40 Years or Older Detected from Primary Care. Frontiers in Medicine (Lausanne), 10, Article ID: 1229972.
https://doi.org/10.3389/fmed.2023.1229972
|
[63]
|
Agrafiotis, M., Galanou, A., Fletsios, D., Chassiotou, A., Chloros, D. and Steiropoulos, P. (2022) Functional Comorbidity Index and Health-Related Quality of Life in Patients with Ob-structive Sleep Apnea. Advances in Respiratory Medicine, 90, 77-85. https://doi.org/10.5603/ARM.a2022.0001
|
[64]
|
Howell, M., Avidan, A.Y., Foldvary-Schaefer, N., et al. (2023) Management of REM Sleep Behavior Disorder: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine, 19, 759-768.
https://doi.org/10.5664/jcsm.10424
|
[65]
|
Erkent, I., Elibol, B., Saka, E., Saygi, S. and Tezer, I. (2023) Sleep Disor-ders and Polysomnography Findings in Patients with Autoimmune Encephalitis. Neurological Sciences, 44, 1351-1360.
https://doi.org/10.1007/s10072-022-06513-x
|
[66]
|
Brunetti, V., Della Marca, G., Spagni, G. and Iorio, R. (2019) Immunotherapy Improves Sleep and Cognitive Impairment in Anti-IgLON5 Encephalopathy. Neurology Neuroim-munology & Neuroinflammation, 6, e577.
https://doi.org/10.1212/NXI.0000000000000577
|